Report Categories
View AllRecent Articles
View All
Brookfield BIP Q1 2026 Disappoints EPS 020 Below 022 Views
Bessent Projects Substantial Disinflation Ahead Amid Speculation of Warsh Fed Appointment
Arcadia Biosciences RKDA Q3 2025 Beat Revenue NA EPS Exceeds by Significant
India Readies Major Tax Administration Overhaul to Ensure Smooth GST Rollout
Music Catalogs Attract Institutional Capital as SonyGIC Joint Venture Acquires Recognition Music Group for 4 Billion
Loop Capital Initiates American Express Coverage with Buy Rating Names It Top Pick
Tempus AI Launches ArteraAI Prostate Test Pioneering Digital Pathology Algorithm for Prostate Cancer
Novartis Lifts FullYear Sales and Profit Forecasts Amid Strong Operational Momentum
JPMorgans Annual Summer Reading List for Wealthy Clients Includes AI Leadership and Lemons
BURU Q3 2023 Earnings Significant Loss Per Share Amid PreRevenue Stage
CLRB Q1 2026 Earnings EPS Surprise Signals Progress Despite PreRevenue Status
SSM Q1 2026 Earnings Loss per Share of 059 as PreRevenue Development Continues
Rubrik Inc RBRK Q1 2026 Earnings Strong EPS Surprise Signals Operating Leverage
ADTX Q3 2025 Earnings Significant Loss per Share Amidst No Revenue Reported Stock Plunges
Ready Capital Senior Notes RCD Hold Steady Near Par Amid Modest Trading
Green Brick Partners Holds Near Support Amid Modest Decline
InMed Pharmaceuticals INM Holds Steady Near Key Support Levels
Hub Cyber Security Warrant HUBCW Inches Higher at 001 Amid Minimal Volume
JPMorgan CEO Jamie Dimon Wall Street Clients Gung Ho Despite Rising Expenses Outlook
Jobless Claims Remain Near Historic Lows Signaling Tight Labor Market
FC Barcelona Confirms Alexia Putellas Departure After 14 TrophyLaden Seasons
Prediction Markets Suggest Growing Likelihood of Fed Rate Hike by July 2027
MNST Q1 2026 Earnings EPS Surpasses Estimates as Stock Ticks Lower
JOE Q1 2026 Earnings EPS of 024 Meets Expectations Stock Declines Slightly
Adagene Q2 2025 Earnings Clinical Progress Overshadows EPS Miss Shares Jump
Aaron Carter Wrongful Death Case Highlights Liability Risks for Physicians and Pharmacies in Opioid Crisis
Ingles Markets IMKTA Q1 2026 Earnings Solid Profitability Amid Unusual Disclosure
Marker Therapeutics Q1 2026 Earnings Loss Narrows as Clinical Progress Continues